Danske Bank A/s »

Moleculin Biotech shares owned by Danske Bank A/s

Quarter-by-quarter ownership of Moleculin Biotech (MBRX) shares owned by Danske Bank A/s from 13F filings

Historical chart of Danske Bank A/s investment in Moleculin Biotech

Tip: Access up to 7 years of quarterly data

All positions including Moleculin Biotech held by Danske Bank A/s consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moleculin Biotech by Danske Bank A/s

Quarter filed Position value Share count Share price at filing
2025-12-31 $7 2 3.50

More positions owned by Danske Bank A/s

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Visa Com Cl A (V)
Johnson & Johnson (JNJ)
Berkshire Hathaway Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Danske Bank A/s

Top funds holding Moleculin Biotech

Jane Street
Vanguard Group
Geode Capital Management
UBS Group
Tower Research Capital
BlackRock
EFG International
Pinnacle Wealth Planning Services
Rockefeller Capital Management
Newbridge Financial Services Group
SBI Securities
Danske Bank A/s
CVA Family Office
Advisor Group Holdings

View all funds holding Moleculin Biotech